参考文献/References:
［1］ TREEDE R D,JENSEN T S,CAMPBELL J N,CRUCCU G,DOSTROVSKY J O,GRIFFIN J W,et al.Carpathian pain:redefinition and a grading system for clinical and research purposes［J］.Neurology,2008,70(18):1630-1635.
［2］ VAN HECKE O,AUSTIN S K,KHAN R A et al.Neuropathic pain in the general population:a systematic review of epidemiological studies［J］.Pain,2014,155:654-662.
［3］ ROSENTHAL P,BORSOOK D,MOULTON E A.Oculofacial pain:Corneal nerve damage leading to pain beyond the eye［J］.Invest Ophthalmol Vis Sci,2016,57(13):5285-5287
［4］ GOYAL S,HAMRAH P.Understanding neuropathic corneal pain-gaps and current therapeutic approaches［J］.Semin Ophthalmol,2016,31(1-2):59-70.
［5］ MCMONNIES C W.The potential role of neuropathic mechanisms in dry eye syndromes［J］.J Optom,2017,10(1):5-13.
［6］ HEGARTY D M,HERMES S M,YANG K,AICHER S A.Select noxious stimuli induce changes on corneal nerve morphology［J］.J Comp Neurol,2017,525(8):2019-2031.
［7］ YANG A Y,CHOW J,LIU J.Corneal innervation and sensation:The eye and beyond［J］.Yale J Biol Med,2018,91(1):13-21.
［8］ BELMONTE C,ACOSTA M C,GALLAR J.Neural basis of sensation in intact and injured corneas［J］.Exp Eye Res,2004,78(3):513-525.
［9］ PROKOPETC K,BARTOLI A.SLIM(slit lamp image mosaicing):handling reflection artifacts［J］.Int J Comput Assist Radiol Surg,2017,12(6):911-920.
［10］ BUNYA V Y,CHEN M,ZHENG Y,MASSARO-GIORDANO M,GEE J,DANIEL E,et al.Development and evaluation of semiautomated quantification of lissamine green staining of the bulbar conjunctiva from digital images［J］.JAMA Ophthalmol,2017,135(10):1078-1085.
［11］ DIECKMANN G,GOYAL S,HAMRAH P.Neuropathic corneal pain:approaches for management［J］.Ophthalmology,2017,124(11 Suppl):S34-S47.
［12］ THULASI P,DJALILIAN A R.Update in current diagnostics and therapeutics of dry eye disease［J］.Ophthalmology,2017,124(11S):S27-S33.
［13］ SACCHETTI M,LAMBIASE A.Neurotrophic factors and corneal nerve regeneration［J］.Neural Regen Res,2017,12(8):1220-1224.
［14］ WEN Q,FAN T,BAI S,SUI Y.Cytotoxicity of proparacaine to human corneal endothelial cells in vitro［J］.J Toxicol Sci,2015,40(4):427-436
［15］ MCLACHLAN E M,HU P.Inflammation in dorsal root ganglia after peripheral nerve injury: effects of the sympathetic innervation［J］.Auton Neurosci,2014,182:108-117.
［16］ SHEPPARD J D,COMSTOCK T L,CAVET M E.Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure［J］.Adv Ther,2016,33(4):532-552.
［17］ AMON M,BUSIN M.Loteprednol etabonate ophthalmic suspension 0.5%:efficacy and safety for postoperative anti-inflammatory use［J］.Int Ophthalmol,2012,32(5):507-517.
［18］ OTHMAN T M,MOUSA A,GIKANDIP W,ABDELMABOD M,ABDELRAHMAN A M.Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease［J］.Saud J Ophthalmol,2018,32( 3):217-221.
［19］ LALLEMAND F,SCHMITT M,BOURGES J L,GURNY R,BENITA S,GARRIGUE J S.Cyclosporine A delivery to the eye:A comprehensive review of academic and industrial efforts［J］.Eur J Pharm Biopharm,2017,117:14-28.
［20］ FABIANI C,SOTA J,TOSI G M,FRANCESCHINI R,FREDIANI B,GALEAZZI M,et al.The emerging role of interleukin(IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases［J］.Clin Rheumatol,2017,36(10):2307-2318.
［21］ ZHANG L,SU Z,ZHANG Z,LIN J,LI D Q,PFLUGFELDER S C.Effects of azithromycin on gene expression profiles of proinflammatory and anti-inflammatorymediators in the eyelid margin and conjunctiva of patients with meibomian gland disease［J］.JAMA Ophthalmol,2015,133(10):1117-1123.
［22］ HIGUCHI A.Autologous serum and serum components［J］.Invest Ophthalmol Vis Sci,2018,59(14):DES121-DES129.
［23］ READ SP,RODRUGUEZ M,DUBOVY S,KARP C L,GALOR A.Treatment of refractory filmentary keratitis with autoglogous serum tears［J］.Eye Contact Lens,2017,43(5):e16-e18.
［24］ TAHMAZ V,GEHLSEN U,SAUERBIER L,HOLTICK U,ENGEL L,RADOJSKA S,et al.Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system:a retrospective cohort study［J］.Br J Ophthalmol,2017,101(3):322-326.
［25］ ABEDI F,HAMRAH P.Corneal subbasal nerve recovery in an acute case of ultraviolet keratitis treated with autologous serum eye drops［J］.J Opthalmol,2018,2018:49054873
［26］ MIAN S Z,AGRANAT J S,JACOBS D S.Prosthetic replacement of the Ocular Surface Ecosystem(PROSE) treatment for complications after LASIK［J］.Eye Contact Lens,2016,42(6):371-373.
［27］ SINDRUP S H,OTTO M,FINNERUP N B,JENSEN T S.Antidepressants in the treatment of neuropathic pain［J］.Basic Clin Pharmacol Toxicol,2005,96(6):399-409.
［28］ GILLMAN P K.Tricyclic antidepressant pharmacology and therapeutic drug interactions updated［J］.Br J Pharmacol,2007,151(6):737-748.
［29］ ROLLMAN B L,BLOCK M R,SCHULLBERG H C.Symptoms of major depression and tricyclic side effects in primary care patients［J］.J Gen Intern Med,1997,12(5):284-291.
［30］ AL-QULITI K W.Update on neuropathic pain treatment for trigeminal neuralgia.The pharmacological and surgical options［J］.Neurosciences(Riyadh),2015,20(2):107-114.
［31］ HUTCHINSON M R,ZHANG Y,BROWN K,COATS B D,SHRIDHAR M,SHOLAR PW,et al.Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone:involvement of toll-like receptor 4(TLR4)［J］.Eur J Neurosci,2008,28(1):20-29.
［32］ PINEDA-FARIAS J B,CARAM-SALAS N L,SALINAS-ABARCA A B,OCAMPO J,GRANADOS-SOTO V.Ultra-low doses of naltrexone enhance the antiallodynic effect of pregabalin or gabapentin in neuropathic rats［J］.Drug Dev Res,2017,78(8):371-380.
［33］ DUEHMKE R M,DERRY S,WIFFEN P J,BELL R F,ALDINGTON D,MOORE R A.Tramadol for neuropathic pain in adults［J］.Cochrane Database Syst Rev,2017,6:CD003726.
［34］ WIFFEN P J,DERRY S,BELL R F,RICE A S,TOLLE TR,PHILLIPS T,et al.Gabapentin for chronic neuropathic pain in adults［J］.Cochrane Database Syst Rev,2017,2017(6) :CD007938.
［35］ FINNERUP NB,ATTAL N,HAROUTOUNIAN S,MCNICOL E,BARON R,DWORKIN RH,et al.Pharmacotherapy for neuropathic pain in adults:a systematic review and meta-analysis［J］.Lancet Neurol,2015,14(2):162-173.
［36］ LI J,YE L.Effect of pregabalin for the treatment of chronic refractory cough:A case report［J］.Medicine(Baltimore),2019,98(23):e15916.
［37］ LI J,CHEN X,LU X,ZHANG C,SHI Q,FENG L.Pregabalin treatment of peripheral nerve damage in amurine diabetic peripheral neuropathy model［J］.Acta Endocrinol(Buchar),2018,14(3):294-299.
［38］ MENG J,ZHANG Q,YANG C,XIAO L,XUE Z,ZHU J.Duloxetine,a balanced serotonin-norepinephrine reuptake inhibitor,improves painful chemotherapy-induced peripheral neuropathy by inhibiting activation of p38 MAPK and NF-κB［J］.Front Pharmacol,2019,10:365.
［39］ POLYCHRONIOU P E,MAYBERG H S,CRAIGHEAD W E,RAKOFSKY J J,APONTE RIVERA V,HAROON E,et al.Temporal profiles and dose-responsiveness of side effects with escitalopram and duloxetine in Treatment-Na ve Depressed Adults［J］.Behav Sci(Basel),2018,8(7):64.
［40］ WANG J,LI Q,XU B,ZHANG T,CHEN S,LUO Y.Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy［J］.Chin J Cancer Res,2017,29(5):411-418.
［41］ GALLAGHER H C,GALLAGHER R M,BUTLER M,BUGGY DJ,HENMAN MC.Venlafaxine for neuropathic pain in adults［J］.Cochrane Database Syst Rev,2015,8:CD011091.
［42］ KOPSKY D J,KEPPEL HESSELINK J M.Topical phenytoin for the treatment of neuropathic pain［J］.J Pain Res,2017,10:469-473.
［43］ JU Z Y,WANG K,CUI H S,YAO Y,LIU S M,ZHOU J,et al.Acupuncture for neuropathic pain in adults［J］.Cochrane Database Syst Rev,2017,12:CD012057.
［44］ JIN Y,XING G,LI G,WANG A,FENG S,TANG Q,et al.High frequency repetitive transcranial magnetic stimulation therapy for chronic neuropathic pain:A meta-analysis［J］.Pain Physician,2015,18(6):E1029-1046.
［45］ PARK H S,KIM W J,KIM H G,YOO S H.Scrambler therapy for the treatment of neuropathic pain related to leukemia in a pediatric patient:A case report［J］.Medicine(Baltimore),2017,96(45):e8629.
［46］ ALMEIDAl C,DEMAMAN A,KUSUDA R,CADETTI F,RAVANELLI M I,QUEIROZ A L,et al.Exercise therapy normalizes BDNF upregulation and glial hyperactivity in a mouse model of neuropathic pain［J］.Pain,2015,156(3):504-513.
［47］ WENDELL S G,BAFFI C,HOLGUIN F.Fatty acids,inflammation,and asthma［J］.J Allergy Clin Immunol,2014,133(5):1255-1264.
［48］ ZIS P,SARRIGIANNIS P G,RAO D G,HADJIVASSILIOU M.Gluten neuropathy:prevalence of neuropathic pain and the role of gluten-free diet［J］.J Neurol,2018,265(10):2231-2236.